These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 18352811
21. Fibrodysplasia ossificans progressiva: a current review of imaging findings. Bauer AH, Bonham J, Gutierrez L, Hsiao EC, Motamedi D. Skeletal Radiol; 2018 Aug; 47(8):1043-1050. PubMed ID: 29445932 [Abstract] [Full Text] [Related]
23. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. van Dinther M, Visser N, de Gorter DJ, Doorn J, Goumans MJ, de Boer J, ten Dijke P. J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436 [Abstract] [Full Text] [Related]
24. Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressiva. de Gorter DJ, Jankipersadsing V, Ten Dijke P. Curr Pharm Des; 2012 Jun; 18(27):4087-92. PubMed ID: 22630080 [Abstract] [Full Text] [Related]
25. Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22. Lucotte G, Bathelier C, Mercier G, Gérard N, Lenoir G, Sémonin O, Fontaine K, FOP Consortium. Fibrodysplasia Ossificans Progressiva Consortium. Genet Couns; 2000 Jun; 11(4):329-34. PubMed ID: 11140409 [Abstract] [Full Text] [Related]
26. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Ohte S, Shin M, Sasanuma H, Yoneyama K, Akita M, Ikebuchi K, Jimi E, Maruki Y, Matsuoka M, Namba A, Tomoda H, Okazaki Y, Ohtake A, Oda H, Owan I, Yoda T, Furuya H, Kamizono J, Kitoh H, Nakashima Y, Susami T, Haga N, Komori T, Katagiri T. Biochem Biophys Res Commun; 2011 Apr 01; 407(1):213-8. PubMed ID: 21377447 [Abstract] [Full Text] [Related]
27. Optimal treatment of fibrodysplasia ossificans progressiva with surgical excision of heterotopic bone, indomethacin, and irradiation. Benetos IS, Mavrogenis AF, Themistocleous GS, Kanellopoulos AD, Papagelopoulos PJ, Soucacos PN. J Surg Orthop Adv; 2006 Apr 01; 15(2):99-104. PubMed ID: 16919202 [Abstract] [Full Text] [Related]
28. Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients. Lucotte G, Houzet A, Hubans C, Lagarde JP, Lenoir G. Genet Couns; 2009 Apr 01; 20(1):53-62. PubMed ID: 19400542 [Abstract] [Full Text] [Related]
29. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call. Towler OW, Shore EM, Xu M, Bamford A, Anderson I, Pignolo RJ, Kaplan FS. Eur J Med Genet; 2017 Jul 01; 60(7):399-402. PubMed ID: 28473268 [Abstract] [Full Text] [Related]
30. Scalp nodules as a presenting sign of fibrodysplasia ossificans progressiva: a register-based study. Piram M, Le Merrer M, Bughin V, De Prost Y, Fraitag S, Bodemer C. J Am Acad Dermatol; 2011 Jan 01; 64(1):97-101. PubMed ID: 21055844 [Abstract] [Full Text] [Related]
31. Fibrodysplasia ossificans progressiva: diagnosis and surgical management. Trigui M, Ayadi K, Zribi M, Triki Z, Keskes H. Acta Orthop Belg; 2011 Apr 01; 77(2):139-44. PubMed ID: 21667723 [Abstract] [Full Text] [Related]
32. Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature. Soldić Z, Murgić J, Radić J, Dabelić N, Jazvić M, Brozić JM, Kusić Z. Coll Antropol; 2011 Jun 01; 35(2):611-4. PubMed ID: 21755739 [Abstract] [Full Text] [Related]
33. Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Gannon FH, Kaplan FS, Olmsted E, Finkel GC, Zasloff MA, Shore E. Hum Pathol; 1997 Mar 01; 28(3):339-43. PubMed ID: 9042799 [Abstract] [Full Text] [Related]
34. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP). Kaplan FS, Al Mukaddam M, Pignolo RJ. Bone; 2017 Aug 01; 101():123-128. PubMed ID: 28465250 [Abstract] [Full Text] [Related]
35. The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator. Lin H, Shi F, Gao J, Hua P. Biosci Rep; 2019 Aug 30; 39(8):. PubMed ID: 31341010 [Abstract] [Full Text] [Related]
36. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice. Kawao N, Yano M, Tamura Y, Okumoto K, Okada K, Kaji H. J Bone Miner Metab; 2016 Sep 30; 34(5):517-25. PubMed ID: 26204847 [Abstract] [Full Text] [Related]
37. Heterotopic ossification on the volar surface of the distal radius in a child with fibrodysplasia ossificans progressiva: challenges in surgical excision of a rare condition. Sirin E, Okay E, Khalilov T, Turkoz K, Erol B, Tetik C. Hand Surg Rehabil; 2021 Apr 30; 40(2):194-197. PubMed ID: 33508521 [Abstract] [Full Text] [Related]
38. Fibrodysplasia ossificans progressiva in two half-sisters: evidence for maternal mosaicism. Janoff HB, Muenke M, Johnson LO, Rosenberg A, Shore EM, Okereke E, Zasloff M, Kaplan FS. Am J Med Genet; 1996 Feb 02; 61(4):320-4. PubMed ID: 8834042 [Abstract] [Full Text] [Related]
39. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent. Upadhyay J, Xie L, Huang L, Das N, Stewart RC, Lyon MC, Palmer K, Rajamani S, Graul C, Lobo M, Wellman TJ, Soares EJ, Silva MD, Hesterman J, Wang L, Wen X, Qian X, Nannuru K, Idone V, Murphy AJ, Economides AN, Hatsell SJ. J Bone Miner Res; 2017 Dec 02; 32(12):2489-2499. PubMed ID: 28782882 [Abstract] [Full Text] [Related]
40. Fibrodysplasia ossificans progressiva (FOP). Paim LB, Liphaus Bde L, Almeida da Silva CA. Indian Pediatr; 2003 Aug 02; 40(8):786-8. PubMed ID: 12951384 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]